| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 12 |
| 1 | OMEPRAZOLE | 10 |
| 2 | OMEPRAZOLE MAGNESIUM | 10 |
| 3 | PANTOPRAZOLE | 8 |
| 4 | DEXAMETHASONE | 7 |
| 5 | DEXAMETHASONE 1.5 MG | 7 |
| 6 | PREDNISOLONE | 7 |
| 7 | PREDNISOLONE ORAL | 7 |
| 8 | PREDNISOLONE ORAL SOLUTION | 7 |
| 9 | ASPIRIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NYSTATIN TOPICAL POWDER | 1 | 0.0312 |
| 1 | PHENAZOPYRIDINE HYDROCHLORIDE | 1 | 0.0030 |
| 2 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 3 | SEBETRALSTAT | 1 | 0.0019 |
| 4 | BESIFLOXACIN | 1 | 0.0010 |
| 5 | UREA | 2 | 0.0009 |
| 6 | HYDROXYZINE PAMOATE | 3 | 0.0008 |
| 7 | BUPRENORPHINE AND NALOXONE | 1 | 0.0008 |
| 8 | GLYCEROL PHENYLBUTYRATE | 1 | 0.0007 |
| 9 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 26 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 2 | Proton Pump Inhibitor [EPC] | 12 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 4 | Benzodiazepine [EPC] | 8 |
| 5 | Osmotic Laxative [EPC] | 7 |
| 6 | Thalidomide Analog [EPC] | 7 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 6 |
| 8 | Kinase Inhibitor [EPC] | 6 |
| 9 | Opioid Agonist [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 7 | Interleukin-31 Receptor alpha Antagonist [EPC] | 2 | 0.0001 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 9 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |